Search Results - "Donnellan, P."

Definitive Results of a Phase III Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Operable, Node-Positive Breast Cancer: The NSABP B-38 Trial by SWAIN, Sandra M, GONG TANG, BRUFSKY, Adam M, BIGGS, David D, LEVINE, Edward A, ZAPAS, John L, PROVENCHER, Louise, NORTHFELT, Donald W, PAIK, Soonmyung, COSTANTINO, Joseph P, MAMOUNAS, Eleftherios P, WOLMARK, Norman, GEYER, Charles E, RASTOGI, Priya, ATKINS, James N, DONNELLAN, Paul P, FEHRENBACHER, Louis, AZAR, Catherine A, ROBIDOUX, André, POLIKOFF, Jonathan A

“…Anthracycline- and taxane-based three-drug chemotherapy regimens have proven benefit as adjuvant therapy for early-stage breast cancer. This trial (NSABP B-38;…”
Get full text

Epileptic dyskinetic encephalopathy in KBG syndrome: Expansion of the phenotype by Donnellan, Eoin P., Gorman, Kathleen M., Shahwan, Amre, Allen, Nicholas M.

“…•ANKRD11 is a new causative gene linked to epileptic dyskinetic encephalopathy.•Epileptic dyskinetic encephalopathy can occur in KBG syndrome.•Epileptic spasms…”
Get full text

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS) by Roncolato, F.T., O'Connell, R.L., Joly, F., Lanceley, A., Hilpert, F., Buizen, L., Okamoto, A., Aotani, E., Salutari, V., Donnellan, P., Oza, A., Avall-Lundqvist, E., Berek, J., Fehm, T., Ledermann, J., Roemer-Becuwe, C., Stockler, M.R., King, M.T., Friedlander, M.L.

“…Potentially platinum sensitive recurrent ovarian cancer (PPS ROC) is defined by a platinum-free interval of >6 months, and usually treated with platinum-based…”
Get full text

Liquid air energy storage systems: A review by O'Callaghan, O., Donnellan, P.

“…Liquid Air Energy Storage (LAES) systems are thermal energy storage systems which take electrical and thermal energy as inputs, create a thermal energy…”
Get full text

Thrombolysis and Iliofemoral Vein Stent Placement in Cancer Patients with Lower Extremity Swelling Attributed to Lymphedema by O’Sullivan, Gerard J., MD, Waldron, Dymphna, MD, Mannion, Eileen, MD, Keane, Maccon, MD, Donnellan, Paul P., MD

“…Abstract Purpose To assess the effects of iliofemoral vein stent placement on symptomatic lower extremity swelling (LES), presumed to be lymphedema, in…”
Get full text

MON-PP004: The Impact of Body Composition Parameters on Ipilimumab Toxicity in Metastatic Melanoma and Longitudinal Changes in Body Composition During Treatment by Daly, L.E, O’Reilly, A, Donnellan, P, Cushen, S, Woodlock, D, Power, D, Aoife, R

Get full text

3339 The impact of body composition parameters on ipilimumab toxicity in metastatic melanoma and longitudinal changes in body composition during treatment by Daly, L, O'Reilly, A, Donnellan, P, Cushen, S, Woodlock, D, Twomey, M, Ryan, A, Power, D

Get full text

Aromatase inhibitors and arthralgia by Donnellan, P P, Douglas, S L, Cameron, D A, Leonard, R C

Get full text

1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10 by Gullo, G, Kennedy, J, Breathnach, O, McCaffrey, J, Keane, M, Martin, M, Gupta, R, Leonard, G, Calvert, P, Donnellan, P, Walshe, J, Mc Dermott, E, Cairney, S, Bose, R, Scott, K, Hernando, A, Parker, I, Tryfonopoulos, D, Moulton, B, Crown, J

Get full text

Macrocephaly Following the Bidirectional Glenn Procedure by Donnellan, Eoin P., O'Brien, Stephen T., Allen, Nicholas M.

Get full text

A review of sentinel lymph node biopsy for thin melanoma by Joyce, K. M., McInerney, N. M., Joyce, C. W., Jones, D. M., Hussey, A. J., Donnellan, P., Kerin, M. J., Kelly, J. L., Regan, P. J.

“…Introduction Although there is a lack of established survival benefit of sentinel lymph node biopsy (SLNB), this technique has been increasingly applied in the…”
Get full text

The 2017 and 2022 ILAE epilepsy classification systems identify needs and opportunities in care: A paediatric hospital-based study by Donnellan, Eoin P., Kehoe, Caroline, Moran, Ailbhe, Ni Chollatain, Maire, Hynes, Yvonne, Hennessy, Michael, Reade, Elaine, Allen, Nicholas M.

“…•Hospital study describing 356 children using 2017/2022 ILAE classifications•Distinct Epilepsy Syndrome identifiable in 40.7%•Neuro-developmental comorbidities…”
Get full text

7162 POSTER A Pan-European Study of Treatment (trx) Patterns and Toxicity of Angiogenesis Inhibitors in Patients (pts) With Advanced Renal Cell Carcinoma (RCC) by Levy, A, Porta, C, Hawkins, R, Bellmunt, J, Wagstaff, J, Donnellan, P, Neary, M.R, Sarda, S.R, Vekeman, F, Duh, M.S

Get full text

PCN21 PATTERNS OF ANGIOGENESIS INHIBITOR TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN IRELAND by McDermott, R, Donnellan, P, McCaffery, J, Keane, F, Sarda, S.P, Korves, C, Luka, A, Wei, R, Neary, M.P, Hanley, R, Duh, M.S

Get full text

Evaluation of carboplatin dosage based on 4-variable modification of diet in renal disease equation by Barry, A., O’Cearbhaill, R., Griffin, D., Donnellan, P., Keane, M., Grimes, H.

“…Background Traditionally, carboplatin dosage is based on the Calvert formula. Glomerular filtration rate (GFR) and creatinine clearance (CrCl) are often used…”
Get full text

1986P MDM2 amplification and hyperprogression following treatment with immune checkpoint inhibitors in advanced non-small cell lung cancer by Cowzer, D., Blazkova, S., Henry, S., Donnellan, P., Hynes, S.

Get full text

How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC) by Roncolato, Felicia, O'Connell, Rachel, Joly, Florence, Lanceley, Anne, Hilpert, Felix, Okamoto, Aikou, Aotani, Eriko, Pignata, Sandro, Donnellan, Paul P., Oza, Amit M., Avall-Lundqvist, Elisabeth, Berek, Jonathan S., Sehouli, Jalid, Ledermann, Jonathan A., Berton-Rigaud, Dominique, Kiely, Belinda Emma, Friedlander, Michael, Stockler, Martin R.

“…Abstract only 5549 Background: Predicting, formulating, and communicating prognosis in women with ROC is difficult. Best-case, worst-case, and typical…”
Get full text

Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior chemotherapy: The GCIG symptom benefit study (SBS) by Roncolato, Felicia, Joly, Florence, O'Connell, Rachel, Lanceley, Anne, Heitz, Florian, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Salutari, Vanda, Donnellan, Paul P., Oza, Amit M., Avall-Lundqvist, Elisabeth, Berek, Jonathan S., Hilpert, Felix, Feeney, Amanda, Roemer-Becuwe, Celia, Stockler, Martin R., King, Madeleine Trudy, Friedlander, Michael

“…Abstract only 5575 Background: PPS ROC is defined by a platinum free interval > 6 months. Women starting ≥3 lines of chemotherapy for PPS ROC are however a…”
Get full text

Comparison of the effect of two types of acupuncture on quality of life in secondary progressive multiple sclerosis: a preliminary single-blind randomized controlled trial by Donnellan, Clare P, Shanley, Jackie

“…Objective: To compare the effect of two types of acupuncture on the quality of life of individuals with secondary progressive multiple sclerosis and provide…”
Get full text

A randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 in the treatment of metastatic malignant melanoma by Nicholson, S, Guile, K, John, J, Clarke, I A, Diffley, J, Donnellan, P, Michael, A, Szlosarek, P, Dalgleish, A G

“…We conducted a randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 (IL-2) as treatment for stage IV malignant melanoma. The…”
Get full text